Details of the Drug

General Information of Drug (ID: DMDQ3XP)

Drug Name

DNX-2401

Synonyms

Tasadenoturev

Indication

Disease Entry	ICD 11	Status	REF
Brain cancer	2A00	Phase 2	[1]
Recurrent glioblastoma	2A00.00	Phase 2	[2]
------------------------------------------------------------------------------------

Drug Type

Oncolytic virus therapy

Cross-matching ID

References

1	ClinicalTrials.gov (NCT02798406) Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects (CAPTIVE). U.S. National Institutes of Health.
2	ClinicalTrials.gov (NCT02798406) Combination Adenovirus + Pembrolizumab to Trigger Immune Virus Effects (CAPTIVE). U.S. National Institutes of Health.